Table 2 Infant demographics and maternal characteristics: no pda versus low pda burden.

From: Association of low shunt burden from PDA and adverse outcomes in premature infants

 

No PDA Burden (n = 69)

Low PDA Burden (n = 43)

p value

Neonatal characteristics

 Birth weight, grams

971 ± 321

1064 ± 287

0.121

 Gestational age, weeks

27.2 ± 2

27.4 ± 2

0.515

 Gestational age <25 weeks

12 (17)

5 (12)

0.589

 Male

32 (46)

20 (47)

1.000

Race

0.485

 Black

10 (14)

7 (16)

 White

47 (68)

31 (72)

 More than one

6 (9)

0

 Other

6 (9)

5 (12)

Hispanic

7 (10)

2 (5)

0.478

Intrauterine growth restriction

13 (19)

3 (7)

0.101

Type of delivery, vaginal

26 (38)

9 (21)

0.093

Delayed cord clamping

40 (58)

29 (67)

0.48

Multiple gestation

14 (20)

14 (33)

0.18

Breech delivery

1 (1)

1 (2)

0.723

Antenatal steroids

65 (94)

39 (91)

0.481

Inborn

64 (94)

32 (74)

0.01

Cord gas pH

7.26 ± 0.1

7.3 ± 0.1

0.084

Maternal characteristics

 Antenatal magnesium

54 (78)

29 (67)

0.978

 Maternal antibiotics

62 (90)

32 (74)

0.244

 Maternal smoker

14 (20)

8 (19)

0.892

 Maternal SSRI use

16 (23)

7 (16)

0.626

 Maternal preeclampsia

13 (19)

6 (14)

0.612

 Preeclampsia with severe features

12 (17)

4 (9)

0.403

 Chronic hypertension

4 (6)

1 (2)

0.653

 Gestational diabetes

6 (9)

5 (12)

0.743

 Maternal obesity

22 (32)

9 (21)

0.279

 Chorioamnionitis

7 (10)

8 (19)

0.254

  1. Data are presented in mean ± SD or frequency (%) as appropriate.
  2. PDA, patent ductus arteriosus, SSRI selective serotonin reuptake inhibitor.
  3. Bolded p-values are those that are statistically significant.